Micropro Softwar (MICROPRO)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 27.83% shows some top-line momentum.
• Latest quarter sales of ₹8 Cr against a ₹31 Cr market cap suggests a rough revenue multiple near 1x if annualised.
• Promoter holding of 46.63% provides some ownership alignment.
• The stock trades closer to its 52-week low of ₹15.15 than its high of ₹28.50, leaving room for a potential operational recovery.

Concerns

• Latest quarter net profit is -₹2 Cr on ₹8 Cr sales, implying a 25% negative net margin.
• Profit growth is down 62.31% and ROCE is -3.38%, indicating poor capital productivity.
• Piotroski F-Score of 3/9 points to weak financial health.
• No dividend, no meaningful book value/debt information, and insufficient data prevent a proper valuation.

AI Analysis

Reading Micropro Softwar's numbers reminds me of a simple rule: investing is the art of the measurable, not the hopeful. This is a ₹31 crore market cap company in software consulting. In the latest quarter it did ₹8 crore of sales but lost ₹2 crore at the net level. Annualised roughly, sales could be around ₹32 crore, so the share price is not expensive on revenue. But no earnings means the P/E of 0.00 is meaningless. A business that loses 25 paise on every rupee of sales cannot command my attention, no matter how fast the top line grows. Sales growth of 27.83% looks encouraging, yet profit growth fell 62.31%. That tells me the growth is not profitable growth. ROCE is -3.38%, so operations are destroying rather than creating capital. The Piotroski F-Score of 3 out of 9 screams financial weakness. There is no dividend, no reliable book value data, and no debt/equity information; I cannot compute a margin of safety if I cannot see the asset side clearly. Graham taught us to buy with a margin of safety. Here, the safety is missing. The 52-week range of ₹15.15 to ₹28.50 shows the market is uncertain. It may someday be a turnaround, but a turnaround is only a good investment when evidence of improving return on capital exists. Today, the evidence points the other way. I would rather miss a possible recovery than risk permanent capital in a small, loss-making business with weak fundamentals. This is not a business I can value, and what I cannot value, I cannot own. For an Indian retail investor, this is a stock to keep on the watch list, not in the portfolio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer